Literature DB >> 9713784

A frequency-doubling perimetric study in normal-tension glaucoma with hemifield defect.

Y Kondo1, T Yamamoto, Y Sato, M Matsubara, Y Kitazawa.   

Abstract

PURPOSE: The authors prospectively compare perimetric results obtained by conventional differential light sensitivity (DLS) perimetry and frequency-doubling perimetry (FDP) in normal-tension glaucoma (NTG) with a hemifield visual field defect, assuming that some of these eyes already have early glaucomatous changes in the "intact" hemifield.
METHODS: Eleven eyes of 11 patients with NTG who met the enrollment criteria were studied. Seven eyes had an upper hemifield defect and four had a lower defect, determined by DLS with a Humphrey Field Analyzer (Zeiss-Humphrey, Inc., San Leandro, CA, U.S.A.). Frequency-doubling perimetry and DLS perimetry were conducted less than 7 days apart. To quantitatively detect nerve fiber layer defect (NFLD), scanning laser ophthalmoscopy was also performed.
RESULTS: Of the 11 intact hemifields, seven showed NFLD. Of the seven, six also showed visual field defects by FDP. Of the four eyes without NFLD, two showed no defects in the intact hemifield by FDP. The threshold values of FDP and DLS perimetry did not significantly correlate in either the intact or the defective hemifields, or in the total field. The average test time of FDP was approximately 6 minutes.
CONCLUSIONS: Frequency-doubling perimetry may detect early glaucomatous visual field defects.

Entities:  

Mesh:

Year:  1998        PMID: 9713784

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  9 in total

1.  Relative hypersensitivity in healthy eye by frequency doubling perimetry in patients with severely damaged contralateral eye.

Authors:  N Fujimoto; D W Zhang; K Minowa; T Hanawa; O Miyauchi; E Adachi-Usami
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Decreased nasal-temporal asymmetry of the second-order kernel response of multifocal electroretinograms in eyes with normal-tension glaucoma.

Authors:  Eijiro Asano; Kiyofumi Mochizuki; Akira Sawada; Ei-Ichiro Nagasaka; Yuji Kondo; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

3.  Comparison of different methods of inter-eye asymmetry of rim area and disc area analysis.

Authors:  A A K Fansi; H Boisjoly; M Chagnon; P J Harasymowycz
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

4.  Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy.

Authors:  P G D Spry; H M Hussin; J M Sparrow
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Agreement between frequency doubling perimetry and static perimetry in eyes with high tension glaucoma and normal tension glaucoma.

Authors:  S Kogure; Y Toda; D Crabb; K Kashiwagi; F W Fitzke; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

6.  Prediction of future scotoma on conventional automated static perimetry using frequency doubling technology perimetry.

Authors:  S Kogure; Y Toda; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

7.  Frequency doubling technology perimetry in non-arteritic ischaemic optic neuropathy with altitudinal defects.

Authors:  C A Girkin; G McGwin; J DeLeon-Ortega
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

8.  Correlation between early retinal nerve fiber layer loss and visual field loss determined by three different perimetric strategies: white-on-white, frequency-doubling, or flicker-defined form perimetry.

Authors:  Verena Prokosch; Nicole Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-30       Impact factor: 3.117

9.  Frequency-doubling technology perimetry and multifocal visual evoked potential in glaucoma, suspected glaucoma, and control patients.

Authors:  Fabio N Kanadani; Paulo Aa Mello; Syril K Dorairaj; Tereza Cm Kanadani
Journal:  Clin Ophthalmol       Date:  2014-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.